United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$82Mraised across 5 rounds since 2007, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by canadianprivateequity.comSEC filing: $19M sold, first sale Aug 2011
Reported by afnm.comSEC filing: $7.0M sold, first sale Aug 2011
No investor was named in the report.
Reported by sec.govSEC filing: $7.0M sold, first sale Aug 2011
No investor was named in the report.
From a historical funding recordSEC filing: $18M sold, first sale Mar 2007
From a historical funding record
From the SEC filings it signed: 2 on the team.
On the board, as filediDamian J.M. LambHamish J.M. CameronRobert J.M. RadieStuart J.M. Collinson
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Forward VenturesOxford Bioscience Partners
Genesys Capital
Genesis CapitalFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Affinium Pharmaceuticals's investors include SV Life Sciences, Forward Ventures, Oxford Bioscience Partners, Genesys Capital and Genesis Capital.
Affinium Pharmaceuticals has raised $82M across 5 rounds since 2007.
Affinium Pharmaceuticals's most recent round was a Debt of $12M in Sept 2013.
Affinium Pharmaceuticals's largest round on record is $19M (Debt), in Aug 2011.
Affinium Pharmaceuticals's first round on record, in Mar 2007, was backed by SV Life Sciences, Oxford Bioscience Partners and Forward Ventures and 1 others.
Affinium Pharmaceuticals's latest named round is a Debt, in Sept 2013.
Affinium Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
